Real World Data in Clinical Trials: Benefits and Best Practices

The utilisation of RWD provides numerous benefits, including improved external validity, broader patient representation, longitudinal data analysis, and improved post-market surveillance.   

However, to maximise the value and reliability of insights derived from RWD, adherence to specific best practices is essential. 

Join your peers to discuss advanced use cases and best practices on leveraging real world data in clinical trials. More specifically, you will collective tackle the following questions: 

• What are some of the most reliable  sources of real world data that are commonly used in clinical trials, and how are they collected and analysed?
• What are the most promising use cases of leveraging RWD in clinical trials? At what juncture of the R&D process is RWD especially useful?
• What are some of the best practices emerging in this space and how can we ensure their adoption across the clinical trials industry?
  

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.